Understanding mesenchymal cancer: the liposarcoma-associated FUS–DDIT3 fusion gene as a model

This publication has 35 references indexed in Scilit:

• Cancer Statistics, 2003
  CA: A Cancer Journal for Clinicians, 2003
• Fusion genes in solid tumors
  Seminars in Cancer Biology, 1999
• CONSEQUENCES OF CHROMOSOMAL ABNORMALITIES IN TUMOR DEVELOPMENT
  Annual Review of Genetics, 1997
• Fusion of the FUS gene with ERG in acute myeloid leukemia with t(16;21)(p11;q22)
  Genes, Chromosomes and Cancer, 1994
• Chromosomal translocations in human cancer
  Nature, 1994
• Transcriptional activation by TAL1 and FUS-CHOP proteins expressed in acute malignancies as a result of chromosomal abnormalities.
  Proceedings of the National Academy of Sciences, 1994
• An ets-related gene, ERG, is rearranged in human myeloid leukemia with t(16;21) chromosomal translocation.
  Proceedings of the National Academy of Sciences, 1993
• Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma
  Nature Genetics, 1993
• Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma
  Nature, 1993
• CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription.
  Genes & Development, 1992